A new study sheds light on a possible biological reason why women are disproportionately affected by Alzheimer’s disease—and it may have to do with the levels of omega-3 fatty acids in their blood. Researchers from King’s College London and Queen Mary University of London have found that women with Alzheimer’s had significantly fewer healthy unsaturated fats, particularly omega fatty acids, compared to women without the disease. This finding could point to a new avenue for prevention and early intervention, especially in women.

Omega-3 fatty acids and brain health have long been linked in scientific literature, but this study, published in Alzheimer's & Dementia: The Journal of the Alzheimer's Association, offers a more detailed look at how these essential nutrients may interact with gender-specific biology. Using mass spectrometry, researchers analyzed over 700 types of lipid molecules in plasma samples from 841 individuals diagnosed with Alzheimer’s disease. What they discovered was a notable imbalance: a steep increase in "unhealthy" saturated fats and a marked decrease in beneficial unsaturated fats in women with the disease.

According to the researchers, saturated lipids are generally considered harmful, while unsaturated lipids—especially those containing omega-3 fatty acids—are viewed as beneficial to health. The blood samples of women with Alzheimer’s showed a significant drop in lipids containing omega-3s, suggesting a potential link between fatty acid levels and the risk or progression of the disease. I found this detail striking, as it offers a tangible biological marker that could help explain the gender disparity in Alzheimer’s diagnoses.

Dr. Asger Wretlind, the study’s first author from the School of Cancer & Pharmaceutical Sciences, emphasized that the findings reveal previously undetected biological differences in lipid profiles between men and women. “Although this still warrants further research, we were able to detect biological differences in lipids between the sexes in a large cohort, and show the importance of lipids containing omegas in the blood, which has not been done before,” Wretlind stated in a press release.

Alzheimer’s disease affects approximately 7 million Americans, and about two-thirds of those diagnosed are women. That staggering figure has long prompted questions about whether hormonal, genetic, or lifestyle factors might be contributing to the increased prevalence in women. This new research adds another layer to that discussion by suggesting that blood lipid composition—specifically the presence or absence of omega-3 fatty acids—may play a role.

Dr. Cristina Legido-Quigley, a co-author of the study and Reader in Systems Medicine, pointed out that the results support the idea that women should be mindful of their omega-3 intake. “Our study suggests that women should make sure they are getting omega fatty acids in their diet – through fatty fish or via supplements,” she said. According to the Centers for Disease Control and Prevention (CDC), omega-3s can be found in foods such as salmon, chia seeds, flaxseeds, and walnuts, as well as in dietary supplements.

While the study does not establish a direct causal relationship between low omega-3 levels and the development of Alzheimer’s, it does highlight a compelling association worth exploring further. Dr. Julia Dudley, head of research at Alzheimer’s Research UK, noted that more investigation is needed to understand the mechanisms behind the observed differences. “This includes understanding the mechanisms behind this difference and finding out if lifestyle changes, including diet, could have a role,” she said.

What makes this research particularly relevant is its potential to inform more personalized approaches to Alzheimer’s prevention and treatment. Dudley emphasized that understanding how Alzheimer’s works differently in women than in men could lead to more tailored medical guidance. “Understanding how the disease works differently in women could help doctors tailor future treatments and health advice,” she explained.

The study also raises questions about when these lipid imbalances begin to emerge. Wretlind mentioned that researchers are now examining how early in life these changes in lipid profiles occur in women. If such differences can be identified earlier in life, it may open the door to preventative strategies that could delay or even reduce the risk of developing Alzheimer’s later on.

Although the findings are preliminary and require further validation through clinical trials, they offer a promising direction for future research. They also underscore the importance of maintaining a balanced diet rich in omega-3 fatty acids, not just for general health but potentially as a protective factor against neurodegenerative diseases.

As the scientific community continues to unravel the complex factors that contribute to Alzheimer’s disease, studies like this one provide valuable insights that can eventually lead to more effective and individualized care. For now, the message is clear: ensuring adequate intake of omega-3 fatty acids may be a small but significant step in supporting brain health, particularly for women.

Read more at foxnews.com